← Back to Clinical Trials
Recruiting NCT02829619

NCT02829619 Meal Timing, Genetics and Weight Loss

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02829619
Status Recruiting
Phase
Sponsor Universidad de Murcia
Condition Obesity
Study Type OBSERVATIONAL
Enrollment 5,788 participants
Start Date 2008-01-01
Primary Completion 2027-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 5,788 participants in total. It began in 2008-01-01 with a primary completion date of 2027-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Meal times differ from culture to culture. These differences may influence energy regulation and, consequently, body weight. Current studies support the notion that not only "what" but also "when" the investigators eat may have a significant role in obesity treatment. Recently, it has been shown that eating the main meal of the day, lunch in Spain, late in the day is predictive of difficulty in weight loss and decreased insulin sensitivity. This project aims to study in a Mediterranean population the potential influence of genetics and food timing on obesity, metabolic syndrome and weight loss.

Eligibility Criteria

Inclusion Criteria: * Body Mass Index: \>25 kg/m2 * Age: \>18 years of age * Caucasian Exclusion Criteria: * Receiving treatment with thermogenic, lipogenic, or contraceptive drugs * Diabetes mellitus, chronic renal failure, hepatic diseases, or cancer diagnosis * bulimia diagnosis, prone to binge eating * undergoing treatment with anxiolytic or antidepressant drugs

Contact & Investigator

Central Contact

Marta Garaulet, PHD

✉ garaulet@um.es

📞 +34-678996368

Principal Investigator

Marta Garaulet, PHD

PRINCIPAL INVESTIGATOR

Universidad de Murcia

Frequently Asked Questions

Who can join the NCT02829619 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02829619 currently recruiting?

Yes, NCT02829619 is actively recruiting participants. Contact the research team at garaulet@um.es for enrollment information.

Where is the NCT02829619 trial being conducted?

This trial is being conducted at Murcia, Spain.

Who is sponsoring the NCT02829619 clinical trial?

NCT02829619 is sponsored by Universidad de Murcia. The principal investigator is Marta Garaulet, PHD at Universidad de Murcia. The trial plans to enroll 5,788 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology